Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer.

Zhou L, Mudianto T, Ma X, Riley R, Uppaluri R
Clin Cancer Res. 2020 Jan 1;26(1):290-300. doi: 10.1158/1078-0432.CCR-19-1351. Epub 2019 Sep 27. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.